Oxford Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-426
| Closed | -$81K | – | 1186 |
|
|
2019
Q4 | $81K | Sell |
426
-216
| -34% | -$41.1K | ﹤0.01% | 1634 |
|
|
2019
Q3 | $124K | Sell |
642
-1,563
| -71% | -$302K | ﹤0.01% | 1613 |
|
|
2019
Q2 | $378K | Buy |
2,205
+1,540
| +232% | +$264K | 0.01% | 1381 |
|
|
2019
Q1 | $134K | Buy |
+665
| New | +$134K | ﹤0.01% | 1545 |
|
|
2018
Q4 | – | Sell |
-1,418
| Closed | -$338K | – | 2089 |
|
|
2018
Q3 | $338K | Sell |
1,418
-1,955
| -58% | -$466K | 0.01% | 1463 |
|
|
2018
Q2 | $899K | Buy |
+3,373
| New | +$899K | 0.02% | 1096 |
|
|
2017
Q4 | – | Sell |
-713
| Closed | -$86K | – | 1859 |
|
|
2017
Q3 | $86K | Buy |
713
+217
| +44% | +$26.2K | ﹤0.01% | 1480 |
|
|
2017
Q2 | $48K | Buy |
+496
| New | +$48K | ﹤0.01% | 1430 |
|